References
- Federici S, Sormani MP, Ozen S, et al. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis. 2015;74(5):799–805. doi:10.1136/annrheumdis-2014-206580
- Haverkamp MH, Van de Vosse E, Goldbach-Mansky R, Holland SM. Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS). Clin Exp Immunol. 2014;177(3):720–731. doi:10.1111/cei.12361
- Sarrabay G, Grandemange S, Touitou I. Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts. Expert Rev Clin Immunol. 2015;11(7):827–835.
- Ben-Chetrit E, Gattorno M, Gul A, et al. Consensus proposal for taxonomy and definition of the inflammatory diseases (AIDs): a Delphi study. Ann Rheum Dis. 2018;77(11):1558–1565. doi:10.1136/annrheumdis-2017-212515
- Tucker LB, Lamot L, Niemietz I, et al. Complexity in unclassified auto-inflammatory disease: a case report illustrating the potential for disease arising from the allelic burden of multiple variants. Pediatr Rheumatol Online J. 2019;17(1):70. doi:10.1186/s12969-019-0374-x
- Gattorno M, Hofer M, Federici S, et al; Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO). Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019;78(8):1025–1032. doi:10.1136/annrheumdis-2019-215048
- Levy R, Gérard L, Kuemmerle-Deschner J, et al. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the eurofever registry. Ann Rheum Dis. 2014:1–7. doi:10.1136/annrheumdis-2013-203953
- Lequerré T, Vittecoq O, Saugier-Veber P, et al. A cryopyrin-associated periodic syndrome with joint destruction. Rheumatology. 2007;46:709–714. doi:10.1093/rheumatology/kel399
- Compeyrot-Lacassagne S, Tran TA, Guillaume-Czitrom S, Marie I, Koné-Paut I. Brain multiple sclerosis-like lesions in a patient with muckle-wells syndrome. Rheumatology. 2009;48(12):1618–1619. doi:10.1093/rheumatology/kep321
- Kilic H, Sahin S, Duman C, et al. Spectrum of the neurologic manifestations in childhood-onset cryopyrin-associated periodic syndrome. Eur J Paediatr Neurol. 2019;23(3):466–472. doi:10.1016/j.ejpn.2019.03.006
- Jang Y, Woo K, Lee ST, Park SH, Chun K, Kun lee S. Cerebral autoinflammatory disease treated with anakinra. Ann Clin Transl Neurol. 2018;5(11):1428–1433. doi:10.1002/acn3.656
- Kenney-Jung D, Kahoud R, Vezzani A, et al. Super-refractory status epilepticus and febrile infection-related epilepsy syndrome treated with anakinra. Ann Neurol. 2016;80(6):939–945. doi:10.1002/ana.24806
- Yokota S, Nishikomori R, Takada H, et al. Guidance on the use of canakinumab in patients with cryopyrin-associated periodic syndrome in Japan. Mod Rheumatol. 2013;23:425–429. doi:10.3109/s10165-012-0769-8
- Treviño SJ, Polo ER. Tratamiento de los síndromes periódicos asociados a la criopirina (CAPS). Med Clin. 2011;136(Supl1):29–33. doi:10.1016/S0025-7753(11)70006-9